THE CIGNA GROUP (CI) Stock News
NYSE:CI - New York Stock Exchange, Inc. - US1255231003 - Common Stock - Currency: USD
CI Latest News, Press Relases and Analysis
Thursday's session: top gainers and losers in the S&P500 index
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Stock market today: S&P 500, Nasdaq leap to fresh records as Vietnam trade deal boosts hopes ahead of key jobs report
Private-sector jobs data prepares the ground for the all-important monthly US jobs report on Friday.
Insurers Aren’t Saying Whether They’ll Cover Vaccines for Kids if Government Stops Recommending Them
RFK Jr.’s vaccine advisory board could stop recommending some routine childhood immunizations, leaving insurers to decide whether to still cover them. For now, most are remaining tight-lipped.
Amazon Wants More Power
Amazon's latest data center will reportedly require the same amount of electricity as 1 million homes.
The Cigna Group Foundation Announces Grants to 24 Nonprofits, Builds on Momentum to Help Address Youth Mental Health Crisis
/PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced its second round of grant recipients...
Here’s Why Cigna Group (CI) Surged in Q1
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The Fund (Investor Shares) fell -2.44% (net of fees) in the quarter, outperforming the S&P 500 Index’s -4.27% return. U.S. equities fell in the first quarter, showing a shift […]
Mentions: NVDA
Cigna sues Bristol Myers for alleged monopoly over blockbuster cancer drug
Cigna accused Bristol Myers Squibb of violating antitrust law by keeping generic versions of its blood cancer drug Pomalyst off the market to retain a monopoly.
Quantum Computing (QUBT) Loses 7.3% on Sudden Management Shakeup
Quantum Computing Inc. (NASDAQ:QUBT) is one of the These 10 Stocks Took A Shocking Fall. Quantum Computing fell for a third straight day on Monday, losing another 7.31 percent to close at $17.50 apiece as investor sentiment was dampened by a sudden management shakeup in the company. This followed the sudden retirement of Christopher Boehmler […]
Mentions: QUBT
Cigna Enhances myCigna Platform With AI Assistant, Personalized Care, Cost Tools
The Cigna Group (NYSE:CI) is one of billionaire Leon Cooperman’s top stock picks with huge upside potential. On June 12, Cigna Healthcare, the health benefits arm of The Cigna Group (NYSE:CI), revealed new digital capabilities designed to enhance the consumer experience during routine health insurance interactions. The myCigna member interface will be used to gradually roll […]
Mentions: LVS
Major Health Insurers Agree to Simplify Prior Authorizations
Major U.S. insurers said they would streamline the prior authorization process.
American insurers to optimize prior authorizations - UPI.com
Major American insurers announced Monday that they have agreed to speed up and smooth out the processes involved with the reception and administration of health care by streamlining the prior authorization process.
Major U.S. health insurers say they will streamline controversial process for approving care
Insurers such as CVS and UnitedHealthcare will implement the changes across commercial, Medicare and Medicaid plans, benefiting 257 million Americans.
Mentions: HUM
Cigna Healthcare Unveils Industry-Leading AI-Powered Digital Tools for a Simple and Reliable Customer Experience
/PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), is introducing a series of new digital features to improve the...
Analysis: Hims & Hers says its weight-loss business can grow as US market changes
(Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some analysts see a need for the online website to adjust to changing competition in the U.S. Hims has thrived in the market for cheaper compounded versions of highly in-demand weight-loss drugs, such as Novo Nordisk's Wegovy. This was allowed by the U.S. Food and Drug Administration when those drugs were in shortage.
US Stocks Lose Support From Asia’s ‘Buy The Dip’ Retail Traders
(Bloomberg) -- When President Donald Trump set off a global stock market slump in April with the announcement of sweeping new tariffs, small investors across Asia rushed to the US stock market to buy the dip. Now, they are backing away.Most Read from BloombergNext Stop: Rancho Cucamonga!Trump Said He Fired the National Portrait Gallery Director. She’s Still There.Where Public Transit Systems Are Bouncing Back Around the WorldNYC Mayoral Candidates All Agree on Building More Housing. But Where?US